Organization | Slovenian Society for Gastroenterology and Hepatology

Slovenian Society for Gastroenterology and Hepatology Report issue

Academic/Hospital

Organization Overview

First Clinical Trial

2020

NCT04359966

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2020

Timeline

NOW

Now

Alternative names

Slovenian Society for Gastroenterology and Hepatology

Active Ingredients

Drugs in Other Trials (6)

amoxicillin (1 trial)

bismuth (1 trial)

clarithromycin (biaxin) (1 trial)

esomeprazole (nexium) (1 trial)

levofloxacin (levaquin) (1 trial)

metronidazole (flagyl) (1 trial)

Indications

Overview

Highest Phase: Phase 0
# of Trials: 1
# of Trial APIs: 6